Skip to content

Clinical trials

Phase 3 ST Elevation Myocardial Infarction trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: ST Elevation Myocardial Infarction Phase: Phase 3 Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20141
20151
20161
20181
20211
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Ottawa Heart Institute Research Corporation2
CeleCor Therapeutics1
Cogentus Pharmaceuticals1
Faraday Pharmaceuticals, Inc.1
GlaxoSmithKline1
Hospital do Coracao1
Montreal Heart Institute1
Population Health Research Institute1
Robert Welsh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
ST Elevation Myocardial Infarction12
Non-ST Elevated Myocardial Infarction6
Myocardial Infarction5
Acute Coronary Syndrome4
Cardiovascular Diseases1
Cerebrovascular Disorders1
Coronary Artery Disease1
Coronary Thrombosis1
Duodenal Obstruction1
Duodenal Ulcer1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.